UniProt ID | IRF4_HUMAN | |
---|---|---|
UniProt AC | Q15306 | |
Protein Name | Interferon regulatory factor 4 | |
Gene Name | IRF4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 451 | |
Subcellular Localization | Nucleus. | |
Protein Description | Transcriptional activator. Binds to the interferon-stimulated response element (ISRE) of the MHC class I promoter. Binds the immunoglobulin lambda light chain enhancer, together with PU.1. Probably plays a role in ISRE-targeted signal transduction mechanisms specific to lymphoid cells. Involved in CD8(+) dendritic cell differentiation by forming a complex with the BATF-JUNB heterodimer in immune cells, leading to recognition of AICE sequence (5'-TGAnTCA/GAAA-3'), an immune-specific regulatory element, followed by cooperative binding of BATF and IRF4 and activation of genes (By similarity).. | |
Protein Sequence | MNLEGGGRGGEFGMSAVSCGNGKLRQWLIDQIDSGKYPGLVWENEEKSIFRIPWKHAGKQDYNREEDAALFKAWALFKGKFREGIDKPDPPTWKTRLRCALNKSNDFEELVERSQLDISDPYKVYRIVPEGAKKGAKQLTLEDPQMSMSHPYTMTTPYPSLPAQQVHNYMMPPLDRSWRDYVPDQPHPEIPYQCPMTFGPRGHHWQGPACENGCQVTGTFYACAPPESQAPGVPTEPSIRSAEALAFSDCRLHICLYYREILVKELTTSSPEGCRISHGHTYDASNLDQVLFPYPEDNGQRKNIEKLLSHLERGVVLWMAPDGLYAKRLCQSRIYWDGPLALCNDRPNKLERDQTCKLFDTQQFLSELQAFAHHGRSLPRFQVTLCFGEEFPDPQRQRKLITAHVEPLLARQLYYFAQQNSGHFLRGYDLPEHISNPEDYHRSIRHSSIQE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
36 | Ubiquitination | IDQIDSGKYPGLVWE HHHHHCCCCCCCEEE | 52.83 | - | |
37 | Phosphorylation | DQIDSGKYPGLVWEN HHHHCCCCCCCEEEC | 13.17 | 20090780 | |
48 | Phosphorylation | VWENEEKSIFRIPWK EEECCCCEEEECCCC | 30.18 | - | |
59 | Ubiquitination | IPWKHAGKQDYNREE CCCCCCCCCCCCHHH | 40.56 | - | |
62 | Phosphorylation | KHAGKQDYNREEDAA CCCCCCCCCHHHHHH | 17.39 | - | |
78 | Malonylation | FKAWALFKGKFREGI HHHHHHHCCCCCCCC | 63.14 | 26320211 | |
103 | Ubiquitination | RLRCALNKSNDFEEL HHHHHHHCCCCHHHH | 52.03 | 22817900 | |
103 (in isoform 1) | Ubiquitination | - | 52.03 | 21906983 | |
103 (in isoform 2) | Ubiquitination | - | 52.03 | 21906983 | |
103 | Acetylation | RLRCALNKSNDFEEL HHHHHHHCCCCHHHH | 52.03 | 12431469 | |
104 | Phosphorylation | LRCALNKSNDFEELV HHHHHHCCCCHHHHH | 40.33 | 30108239 | |
114 | Phosphorylation | FEELVERSQLDISDP HHHHHHHHCCCCCCC | 22.91 | 30177828 | |
119 | Phosphorylation | ERSQLDISDPYKVYR HHHCCCCCCCCCEEE | 32.00 | 30108239 | |
122 | Phosphorylation | QLDISDPYKVYRIVP CCCCCCCCCEEEECC | 20.34 | 20090780 | |
123 | Ubiquitination | LDISDPYKVYRIVPE CCCCCCCCEEEECCC | 37.87 | 22817900 | |
123 (in isoform 2) | Ubiquitination | - | 37.87 | 21906983 | |
123 (in isoform 1) | Ubiquitination | - | 37.87 | 21906983 | |
125 | Phosphorylation | ISDPYKVYRIVPEGA CCCCCCEEEECCCHH | 7.17 | 20090780 | |
140 | Phosphorylation | KKGAKQLTLEDPQMS HHCCCCCCCCCCCCC | 26.13 | 22210691 | |
160 | Phosphorylation | TMTTPYPSLPAQQVH CCCCCCCCCCHHHHH | 40.93 | 22210691 | |
177 | Phosphorylation | MMPPLDRSWRDYVPD CCCCCCCCHHHCCCC | 26.57 | - | |
181 | Phosphorylation | LDRSWRDYVPDQPHP CCCCHHHCCCCCCCC | 12.81 | - | |
192 | Phosphorylation | QPHPEIPYQCPMTFG CCCCCCCCCCCCCCC | 28.54 | 22817900 | |
201 | Methylation | CPMTFGPRGHHWQGP CCCCCCCCCCCCCCC | 58.41 | 115386575 | |
257 | Phosphorylation | CRLHICLYYREILVK CEEHHHHHHHHHHHH | 8.96 | 29083192 | |
258 | Phosphorylation | RLHICLYYREILVKE EEHHHHHHHHHHHHH | 6.71 | 29083192 | |
263 (in isoform 2) | Ubiquitination | - | 5.78 | 21906983 | |
264 | Ubiquitination | YYREILVKELTTSSP HHHHHHHHHHCCCCC | 43.49 | 21906983 | |
264 (in isoform 1) | Ubiquitination | - | 43.49 | 21906983 | |
267 | Phosphorylation | EILVKELTTSSPEGC HHHHHHHCCCCCCCC | 26.23 | 29083192 | |
268 | Phosphorylation | ILVKELTTSSPEGCR HHHHHHCCCCCCCCE | 39.57 | 29083192 | |
269 | Phosphorylation | LVKELTTSSPEGCRI HHHHHCCCCCCCCEE | 38.36 | 29083192 | |
270 | Phosphorylation | VKELTTSSPEGCRIS HHHHCCCCCCCCEEC | 25.52 | 29083192 | |
306 | Ubiquitination | GQRKNIEKLLSHLER CCCCCHHHHHHHHHH | 51.43 | - | |
309 | O-linked_Glycosylation | KNIEKLLSHLERGVV CCHHHHHHHHHHCEE | 36.14 | 30379171 | |
325 | Phosphorylation | WMAPDGLYAKRLCQS EECCCCHHHHHHHCC | 18.66 | - | |
326 (in isoform 2) | Ubiquitination | - | 8.78 | 21906983 | |
327 (in isoform 1) | Ubiquitination | - | 32.14 | 21906983 | |
327 | Ubiquitination | APDGLYAKRLCQSRI CCCCHHHHHHHCCCE | 32.14 | 21906983 | |
349 | Ubiquitination | LCNDRPNKLERDQTC ECCCCCCCCCCCCHH | 55.17 | - | |
356 (in isoform 2) | Ubiquitination | - | 2.75 | 21906983 | |
357 (in isoform 1) | Ubiquitination | - | 56.42 | 21906983 | |
357 | Ubiquitination | LERDQTCKLFDTQQF CCCCCHHHCCCHHHH | 56.42 | 2190698 | |
363 | Ubiquitination | CKLFDTQQFLSELQA HHCCCHHHHHHHHHH | 43.25 | 25015289 | |
398 | Ubiquitination | FPDPQRQRKLITAHV CCCHHHHHHHHHHCH | 37.63 | 25015289 | |
399 | Ubiquitination | PDPQRQRKLITAHVE CCHHHHHHHHHHCHH | 35.58 | 25015289 | |
428 | Phosphorylation | SGHFLRGYDLPEHIS CCCCCCCCCCCHHHC | 14.10 | 20090780 | |
435 | Phosphorylation | YDLPEHISNPEDYHR CCCCHHHCCHHHHHH | 48.52 | 30108239 | |
440 | Phosphorylation | HISNPEDYHRSIRHS HHCCHHHHHHHHHHH | 9.47 | 20090780 | |
443 | Phosphorylation | NPEDYHRSIRHSSIQ CHHHHHHHHHHHHCC | 15.63 | 27080861 | |
447 | Phosphorylation | YHRSIRHSSIQE--- HHHHHHHHHCCC--- | 21.20 | 30108239 | |
448 | Phosphorylation | HRSIRHSSIQE---- HHHHHHHHCCC---- | 23.36 | 30108239 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IRF4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IRF4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TRAF2_HUMAN | TRAF2 | physical | 16189514 | |
STAT6_HUMAN | STAT6 | physical | 10601358 | |
BCL6_HUMAN | BCL6 | physical | 10601358 | |
NFAC2_HUMAN | NFATC2 | physical | 11956291 | |
SPI1_HUMAN | SPI1 | physical | 10022840 | |
SPI1_HUMAN | SPI1 | physical | 12372320 | |
PRDM1_MOUSE | Prdm1 | physical | 11342629 | |
PROX1_HUMAN | PROX1 | physical | 20211142 | |
HXB13_HUMAN | HOXB13 | physical | 20211142 | |
BATF_HUMAN | BATF | physical | 20211142 | |
ETV7_HUMAN | ETV7 | physical | 20211142 | |
PRC2B_HUMAN | PRRC2B | physical | 21903422 | |
CARM1_HUMAN | CARM1 | physical | 21903422 | |
ELP1_HUMAN | IKBKAP | physical | 21903422 | |
IRAK1_HUMAN | IRAK1 | physical | 21903422 | |
PEG10_HUMAN | PEG10 | physical | 21903422 | |
TLK2_HUMAN | TLK2 | physical | 21903422 | |
VPS35_HUMAN | VPS35 | physical | 21903422 | |
YTDC2_HUMAN | YTHDC2 | physical | 21903422 | |
BCL6_HUMAN | BCL6 | physical | 11342629 | |
STAT6_HUMAN | STAT6 | physical | 11342629 | |
RIPK2_HUMAN | RIPK2 | physical | 24670424 | |
MYD88_HUMAN | MYD88 | physical | 24670424 | |
TRAF6_HUMAN | TRAF6 | physical | 24670424 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
254500 | Multiple myeloma (MM) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...